Annual ROE
-532.46%
-454.76%-585.28%
30 April 2024
Summary:
Champions Oncology annual return on equity is currently -532.46%, with the most recent change of -454.76% (-585.28%) on 30 April 2024. During the last 3 years, it has fallen by -538.24% (-9312.11%). CSBR annual ROE is now -864.81% below its all-time high of 69.62%, reached on 30 April 2003.CSBR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
323.52%
+1685.56%+123.75%
31 July 2024
Summary:
Champions Oncology quarterly return on equity is currently 323.52%, with the most recent change of +1685.56% (+123.75%) on 31 July 2024. Over the past year, it has increased by +534.23% (+253.54%). CSBR quarterly ROE is now -90.48% below its all-time high of 3397.27%, reached on 31 January 2013.CSBR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSBR ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -585.3% | +253.5% |
| 3 y3 years | -9312.1% | +6157.6% |
| 5 y5 years | -4762.5% | +803.6% |
CSBR ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -8131.1% | at low | at high | +123.8% |
| 5 y | 5 years | -4762.5% | at low | at high | +123.8% |
| alltime | all time | -864.8% | +75.3% | -90.5% | +101.9% |
Champions Oncology ROE History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | 323.52%(-123.8%) |
| Apr 2024 | -532.46%(+585.3%) | -1362.04%(+225.9%) |
| Jan 2024 | - | -417.94%(+98.3%) |
| Oct 2023 | - | -210.71%(+76.5%) |
| July 2023 | - | -119.37%(+74.3%) |
| Apr 2023 | -77.70%(-1271.9%) | -68.48%(+91.3%) |
| Jan 2023 | - | -35.80%(-3058.7%) |
| Oct 2022 | - | 1.21%(-74.1%) |
| July 2022 | - | 4.67%(-29.5%) |
| Apr 2022 | 6.63%(+14.7%) | 6.62%(+142.5%) |
| Jan 2022 | - | 2.73%(-47.2%) |
| Oct 2021 | - | 5.17%(+217.2%) |
| July 2021 | - | 1.63%(-70.5%) |
| Apr 2021 | 5.78%(-110.1%) | 5.52%(-127.9%) |
| Jan 2021 | - | -19.79%(-46.4%) |
| Oct 2020 | - | -36.89%(-5.5%) |
| July 2020 | - | -39.02%(-46.4%) |
| Apr 2020 | -57.05%(-599.6%) | -72.86%(+837.7%) |
| Jan 2020 | - | -7.77%(-83.1%) |
| Oct 2019 | - | -45.98%(-18.0%) |
| July 2019 | - | -56.06%(-732.0%) |
| Apr 2019 | 11.42%(-101.6%) | 8.87%(-138.0%) |
| Jan 2019 | - | -23.37%(-492.1%) |
| Oct 2018 | - | 5.96%(-106.5%) |
| July 2018 | - | -91.95%(-80.8%) |
| Apr 2018 | -732.51%(-66.1%) | -479.84%(+5.0%) |
| Jan 2018 | - | -457.06%(+25.3%) |
| Oct 2017 | - | -364.70%(+32.6%) |
| July 2017 | - | -275.00%(-27.6%) |
| Apr 2017 | -2157.99%(+757.0%) | -379.90%(+18.0%) |
| Jan 2017 | - | -322.08%(+4.0%) |
| Oct 2016 | - | -309.55%(-3.7%) |
| July 2016 | - | -321.47%(+26.5%) |
| Apr 2016 | -251.80%(+7.8%) | -254.05%(-28.8%) |
| Jan 2016 | - | -356.94%(-28.0%) |
| Oct 2015 | - | -495.52%(-33.3%) |
| July 2015 | - | -743.18%(-35.5%) |
| Apr 2015 | -233.48%(+71.4%) | -1152.20%(-58.3%) |
| Jan 2015 | - | -2762.74%(+506.9%) |
| Oct 2014 | - | -455.25%(+90.7%) |
| July 2014 | - | -238.71%(+64.5%) |
| Apr 2014 | -136.23%(+13.6%) | -145.11%(+28.0%) |
| Jan 2014 | - | -113.37%(-40.4%) |
| Oct 2013 | - | -190.10%(-47.6%) |
| July 2013 | - | -362.93%(-21.2%) |
| Apr 2013 | -119.92%(-79.9%) | -460.85%(-113.6%) |
| Jan 2013 | - | 3397.27%(+1417.7%) |
| Oct 2012 | - | 223.85%(-38.5%) |
| July 2012 | - | 364.14%(-59.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2012 | -597.31%(+25.4%) | 892.73%(+70.0%) |
| Jan 2012 | - | 525.04%(-103.1%) |
| Oct 2011 | - | -16.99 K%(+2414.0%) |
| July 2011 | - | -675.77%(+129.4%) |
| Apr 2011 | -476.44%(+184.7%) | -294.64%(+198.2%) |
| Jan 2011 | - | -98.79%(-37.7%) |
| Oct 2010 | - | -158.56%(-31.5%) |
| July 2010 | - | -231.64%(-3.9%) |
| Apr 2010 | -167.36%(+107.3%) | -241.09%(-4.6%) |
| Jan 2010 | - | -252.62%(+30.9%) |
| Oct 2009 | - | -192.94%(+51.0%) |
| July 2009 | - | -127.80%(+71.7%) |
| Apr 2009 | -80.75%(+231.6%) | -74.43%(+24.4%) |
| Jan 2009 | - | -59.83%(+144.4%) |
| Oct 2008 | - | -24.48%(-6.8%) |
| July 2008 | - | -26.26%(-15.1%) |
| Apr 2008 | -24.35%(-137.4%) | -30.92%(-143.4%) |
| Jan 2008 | - | 71.25%(-141.4%) |
| Oct 2007 | - | -171.99%(-111.9%) |
| July 2007 | - | 1449.25%(+3439.9%) |
| Apr 2007 | 65.15%(+43.9%) | 40.94%(+199.5%) |
| Jan 2007 | - | 13.67%(-26.7%) |
| Oct 2006 | - | 18.64%(-7.4%) |
| July 2006 | - | 20.14%(-63.1%) |
| Apr 2006 | 45.29%(-32.6%) | 54.52%(-11.5%) |
| Jan 2006 | - | 61.58%(-9.7%) |
| Oct 2005 | - | 68.22%(-33.7%) |
| July 2005 | - | 102.93%(+17.4%) |
| Apr 2005 | 67.20%(+25.0%) | 87.70%(+19.8%) |
| Jan 2005 | - | 73.21%(-21.9%) |
| Oct 2004 | - | 93.70%(+65.1%) |
| July 2004 | - | 56.75%(+70.6%) |
| Apr 2004 | 53.77%(-22.8%) | 33.27%(-70.1%) |
| Jan 2004 | - | 111.43%(+6.5%) |
| Oct 2003 | - | 104.62%(+44.4%) |
| July 2003 | - | 72.45%(-41.8%) |
| Apr 2003 | 69.62%(-134.5%) | 124.57%(-48.9%) |
| Jan 2003 | - | 243.85%(-112.7%) |
| Oct 2002 | - | -1922.46%(+299.1%) |
| July 2002 | - | -481.65%(+176.4%) |
| Apr 2002 | -201.73%(+55.4%) | -174.26%(-5.6%) |
| Jan 2002 | - | -184.52%(+2.2%) |
| Oct 2001 | - | -180.56%(+16.1%) |
| July 2001 | - | -155.57%(+39.3%) |
| Apr 2001 | -129.83%(-2346.2%) | -111.68%(+80.2%) |
| Jan 2001 | - | -61.97%(+212.3%) |
| Oct 2000 | - | -19.84%(+1904.0%) |
| July 2000 | - | -0.99% |
| Apr 2000 | 5.78% | - |
FAQ
- What is Champions Oncology annual return on equity?
- What is the all time high annual ROE for Champions Oncology?
- What is Champions Oncology annual ROE year-on-year change?
- What is Champions Oncology quarterly return on equity?
- What is the all time high quarterly ROE for Champions Oncology?
- What is Champions Oncology quarterly ROE year-on-year change?
What is Champions Oncology annual return on equity?
The current annual ROE of CSBR is -532.46%
What is the all time high annual ROE for Champions Oncology?
Champions Oncology all-time high annual return on equity is 69.62%
What is Champions Oncology annual ROE year-on-year change?
Over the past year, CSBR annual return on equity has changed by -454.76% (-585.28%)
What is Champions Oncology quarterly return on equity?
The current quarterly ROE of CSBR is 323.52%
What is the all time high quarterly ROE for Champions Oncology?
Champions Oncology all-time high quarterly return on equity is 3397.27%
What is Champions Oncology quarterly ROE year-on-year change?
Over the past year, CSBR quarterly return on equity has changed by +534.23% (+253.54%)